Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
Renovaro Inc
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
03 mars 2025 09h15 HE
|
Renovaro Inc
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
26 févr. 2025 13h25 HE
|
Renovaro Inc
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
Renovaro Announces $15 million in Equity Committed
26 févr. 2025 09h15 HE
|
Renovaro Inc
Renovaro Announces $15 million in Equity Committed
Renovaro Issues Shareholder Letter and Provides Corporate Update
07 janv. 2025 09h15 HE
|
Renovaro Inc
Renovaro Issues Shareholder Letter and Provides Corporate Update
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
07 janv. 2025 09h15 HE
|
Renovaro Inc
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
06 janv. 2025 09h15 HE
|
Renovaro Inc
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
30 déc. 2024 09h00 HE
|
Renovaro Inc
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
23 déc. 2024 09h00 HE
|
Renovaro Inc
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
Renovaro Regains Compliance with NASDAQ Listing Requirement
20 déc. 2024 15h40 HE
|
Renovaro Inc
Renovaro Regains Compliance with NASDAQ Listing Requirement
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
20 déc. 2024 09h00 HE
|
Renovaro Inc
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection